Aging-dependent Loss of Functional Connectivity in a Mouse Model of Alzheimer's Disease and Reversal by MGluR5 Modulator

Overview

Journal Mol Psychiatry

Specialties Molecular Biology
Psychiatry

Date 2024 Oct 18

PMID 39424929

Authors

Francesca Mandino

Xilin Shen

Gabriel Desrosiers-Gregoire

David OConnor

Bandhan Mukherjee

Ashley Owens

An Qu

John Onofrey

Xenophon Papademetris

M Mallar Chakravarty

Stephen M Strittmatter

Evelyn M R Lake

Affiliations

Soon will be listed here.

Abstract

Amyloid accumulation in Alzheimer's disease (AD) is associated with synaptic damage and altered connectivity in brain networks. While measures of amyloid accumulation and biochemical changes in mouse models have utility for translational studies of certain therapeutics, preclinical analysis of altered brain connectivity using clinically relevant fMRI measures has not been well developed for agents intended to improve neural networks. Here, we conduct a longitudinal study in a double knock-in mouse model for AD (App/hMapt), monitoring brain connectivity by means of resting-state fMRI. While the 4-month-old AD mice are indistinguishable from wild-type controls (WT), decreased connectivity in the default-mode network is significant for the AD mice relative to WT mice by 6 months of age and is pronounced by 9 months of age. In a second cohort of 20-month-old mice with persistent functional connectivity deficits for AD relative to WT, we assess the impact of two-months of oral treatment with a silent allosteric modulator of mGluR5 (BMS-984923/ALX001) known to rescue synaptic density. Functional connectivity deficits in the aged AD mice are reversed by the mGluR5-directed treatment. The longitudinal application of fMRI has enabled us to define the preclinical time trajectory of AD-related changes in functional connectivity, and to demonstrate a translatable metric for monitoring disease emergence, progression, and response to synapse-rescuing treatment.

References

Sheline Y, Morris J, Snyder A, Price J, Yan Z, DAngelo G . APOE4 allele disrupts resting state fMRI connectivity in the absence of amyloid plaques or decreased CSF Aβ42. J Neurosci. 2010; 30(50):17035-40. PMC: 3023180. DOI: 10.1523/JNEUROSCI.3987-10.2010. View

Wang J, Zuo X, Dai Z, Xia M, Zhao Z, Zhao X . Disrupted functional brain connectome in individuals at risk for Alzheimer's disease. Biol Psychiatry. 2012; 73(5):472-81. DOI: 10.1016/j.biopsych.2012.03.026. View

Marquez F, Yassa M . Neuroimaging Biomarkers for Alzheimer's Disease. Mol Neurodegener. 2019; 14(1):21. PMC: 6555939. DOI: 10.1186/s13024-019-0325-5. View

Wang X, Huang W, Su L, Xing Y, Jessen F, Sun Y . Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer's disease. Mol Neurodegener. 2020; 15(1):55. PMC: 7507636. DOI: 10.1186/s13024-020-00395-3. View

Chetelat G . Multimodal Neuroimaging in Alzheimer's Disease: Early Diagnosis, Physiopathological Mechanisms, and Impact of Lifestyle. J Alzheimers Dis. 2018; 64(s1):S199-S211. PMC: 6004909. DOI: 10.3233/JAD-179920. View

Sheline Y, Raichle M, Snyder A, Morris J, Head D, Wang S . Amyloid plaques disrupt resting state default mode network connectivity in cognitively normal elderly. Biol Psychiatry. 2009; 67(6):584-7. PMC: 2829379. DOI: 10.1016/j.biopsych.2009.08.024. View

Morris J, Storandt M, McKeel Jr D, Rubin E, Price J, Grant E . Cerebral amyloid deposition and diffuse plaques in "normal" aging: Evidence for presymptomatic and very mild Alzheimer's disease. Neurology. 1996; 46(3):707-19. DOI: 10.1212/wnl.46.3.707. View

Brier M, Thomas J, Ances B . Network dysfunction in Alzheimer's disease: refining the disconnection hypothesis. Brain Connect. 2014; 4(5):299-311. PMC: 4064730. DOI: 10.1089/brain.2014.0236. View

Buckner R, Andrews-Hanna J, Schacter D . The brain's default network: anatomy, function, and relevance to disease. Ann N Y Acad Sci. 2008; 1124:1-38. DOI: 10.1196/annals.1440.011. View

10.

Scheff S, Price D, Schmitt F, Mufson E . Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment. Neurobiol Aging. 2005; 27(10):1372-84. DOI: 10.1016/j.neurobiolaging.2005.09.012. View

11.

Terry R, Masliah E, Salmon D, Butters N, DeTeresa R, Hill R . Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol. 1991; 30(4):572-80. DOI: 10.1002/ana.410300410. View

12.

DeKosky S, Scheff S . Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann Neurol. 1990; 27(5):457-64. DOI: 10.1002/ana.410270502. View

13.

Sze C, Troncoso J, Kawas C, Mouton P, Price D, Martin L . Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease. J Neuropathol Exp Neurol. 1997; 56(8):933-44. DOI: 10.1097/00005072-199708000-00011. View

14.

Morrison J, Baxter M . The ageing cortical synapse: hallmarks and implications for cognitive decline. Nat Rev Neurosci. 2012; 13(4):240-50. PMC: 3592200. DOI: 10.1038/nrn3200. View

15.

Grandjean J, Derungs R, Kulic L, Welt T, Henkelman M, Nitsch R . Complex interplay between brain function and structure during cerebral amyloidosis in APP transgenic mouse strains revealed by multi-parametric MRI comparison. Neuroimage. 2016; 134:1-11. DOI: 10.1016/j.neuroimage.2016.03.042. View

16.

Shah D, Jonckers E, Praet J, Vanhoutte G, Delgado Y Palacios R, Bigot C . Resting state FMRI reveals diminished functional connectivity in a mouse model of amyloidosis. PLoS One. 2013; 8(12):e84241. PMC: 3866274. DOI: 10.1371/journal.pone.0084241. View

17.

Markicevic M, Savvateev I, Grimm C, Zerbi V . Emerging imaging methods to study whole-brain function in rodent models. Transl Psychiatry. 2021; 11(1):457. PMC: 8418612. DOI: 10.1038/s41398-021-01575-5. View

18.

Gorges M, Roselli F, Muller H, Ludolph A, Rasche V, Kassubek J . Functional Connectivity Mapping in the Animal Model: Principles and Applications of Resting-State fMRI. Front Neurol. 2017; 8:200. PMC: 5423907. DOI: 10.3389/fneur.2017.00200. View

19.

Zerbi V, Grandjean J, Rudin M, Wenderoth N . Mapping the mouse brain with rs-fMRI: An optimized pipeline for functional network identification. Neuroimage. 2015; 123:11-21. DOI: 10.1016/j.neuroimage.2015.07.090. View

20.

Grandjean J, Schroeter A, Batata I, Rudin M . Optimization of anesthesia protocol for resting-state fMRI in mice based on differential effects of anesthetics on functional connectivity patterns. Neuroimage. 2014; 102 Pt 2:838-47. DOI: 10.1016/j.neuroimage.2014.08.043. View